| Table 1. Biochemical characteristics in different patient groups. | |||
| LR (n=28) | NR (n=36) | HR (n=13) | |
|---|---|---|---|
| Age (years) | 37.0 (32.0-39.0) | 33.0 (30.0-39.0) | 35.0 (31.0-38.0) |
| BMI (kg/cm2) | 29.5 (25.0-31.0) | 28.9 (26.0-30.0) | 28.7 (28.3-34.0) |
| FSH (UI/L) | 9.0 (6.0-14.0) | 7.4 (6.0-8.5) | 6.9 (5.7-7.5) |
| LH (UI/L) | 6.0 (3.0-8.0) | 5.6 (4.2-8.0) | 5.2 (4.0-7.4) |
| E2 (pg/mL) | 44.0 (33.0-62.9) | 38.0 (29.0-59.0) | 34.0 (28.0-56.0) |
| PRL (µg/L) | 18.0 (13.0-23.0) | 16.0 (12.5-24.0) | 19.0 (14.0-23.0) |
| TSH (mU/L) | 1.6 (1.2-2.1) | 2.0 (1.2-2.5) | 1.8 (0.9-2.1) |
| T4 free (ng/dL) | 1.3 (1.2-1.6) | 1.3 (1.2-1.5) | 1.3 (1.0-1.7) |
| Glucose (mg/dL) | 93.0 (91.0-96.0) | 90.0 (82.0-96.0) | 88.5 (83.0-91.0) |
| Insulin (U/mL) | 10.0 (7.0-14.0) | 11.0 (9.0-17.0) | 7.0 (6.0-8.0) |
| HOMA | 2.4 (1.3-3.0) | 2.4 (1.9-4.0) | 1.6 (1.5-2.5) |
LR: Lower responder; NR: Normal responder; HR: High responder; BMI: body mass index; FSH: Follicle-Stimulating Hormone; LH: luteinizing hormone; E2: estrogen; PRL: prolactin; TSH: Thyroid-stimulating hormone; HOMA: Homeostatic Model Assessment.